Cancer Vaccine Institute News

The biggest challenge in ovarian cancer isn’t getting to remission - it’s staying there. Recurrence rates are high, especially for advanced disease. Nineteen-year survivor and CVI vaccine recipient Jamie Crase captures that stark reality: “Stage 4 ovarian cancer has a 90-95% chance of recurrence after the initial treatment. The odds were not in my favor.” At the Cancer Vaccine Institute, we are changing the odds in the favor of Jamie and all patients diagnosed with this deadl

Every September, Ovarian Cancer Awareness Month reminds us of the urgent need to improve outcomes with a new standard of care for people...

Friday, June 15th-16th, 2023 In-person in Seattle, Washington & Virtually The CVI Circle - Empowering Patients, Advancing Science ("The CVI Circle") is an event organized by the Cancer Vaccine Institute at the University of Washington to bring together patients, clinicians, and researchers. We are proud to partner with our amazing Patient Advisory Council the planning of this event. Our goal is for everyone - patients, clinicians, & scientists - to have the opportunity to pa